Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Non-cash Items (2019 - 2025)

IDEAYA Biosciences' Non-cash Items history spans 7 years, with the latest figure at $96.2 million for Q4 2025.

  • For Q4 2025, Non-cash Items rose 6.65% year-over-year to $96.2 million; the TTM value through Dec 2025 reached $96.2 million, up 6.65%, while the annual FY2025 figure was $96.2 million, 6.65% up from the prior year.
  • Non-cash Items for Q4 2025 was $96.2 million at IDEAYA Biosciences, down from $108.4 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $118.8 million in Q2 2025 and bottomed at $41400.0 in Q4 2021.
  • The 5-year median for Non-cash Items is $47.3 million (2023), against an average of $60.3 million.
  • The largest annual shift saw Non-cash Items surged 67532.85% in 2022 before it increased 6.65% in 2025.
  • A 5-year view of Non-cash Items shows it stood at $41400.0 in 2021, then soared by 67532.85% to $28.0 million in 2022, then skyrocketed by 46.79% to $41.1 million in 2023, then skyrocketed by 119.46% to $90.2 million in 2024, then rose by 6.65% to $96.2 million in 2025.
  • Per Business Quant, the three most recent readings for IDYA's Non-cash Items are $96.2 million (Q4 2025), $108.4 million (Q3 2025), and $118.8 million (Q2 2025).